MAHAFFY PATRICK J 4
4 · Medicus Pharma Ltd. · Filed Jun 4, 2026
Research Summary
AI-generated summary of this filing
Medicus Pharma (MDCX) Director Patrick J. Mahaffy Receives 50,000-Share Option Award
What Happened
- Patrick J. Mahaffy, a director of Medicus Pharma Ltd. (MDCX), received a derivative award on June 3, 2026: an option covering 50,000 shares. The Form 4 reports the transaction as an Award/Grant (code A) with a reported price of $0.00. This was a grant of equity (an option), not a purchase or sale.
Key Details
- Transaction date: June 3, 2026; Form 4 filed June 4, 2026 (timely).
- Transaction type/code: Award/Grant (A); derivative (option) for 50,000 shares; reported price $0.00.
- Shares owned after transaction: not specified in the filing.
- Footnote: The option was granted June 3, 2026 and is scheduled to vest quarterly in four equal installments over one year.
- Filing timeliness: filed next day — not marked late.
Context
- This is a grant of an option award that vests over a year; it is not an exercise or sale and does not itself involve immediate cash proceeds or a market sale. Grants are common compensation for executives and directors and do not directly signal buying/selling in the open market.
Insider Transaction Report
Form 4
MAHAFFY PATRICK J
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-06-03+50,000→ 50,000 totalExercise: $0.36Exp: 2031-06-03→ Common Shares (50,000 underlying)
Footnotes (1)
- [F1]The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year.
Signature
/s/ Raza Bokhari, as Attorney-in-Fact, for Patrick J. Mahaffy|2026-06-04